Human Gene Patenting—An Overview of Legal and Ethical Considerations
by Robin Teskin

Orange Book Games
by Terry Mahn and Jill B. Deal

International Trademark Protection
by Dennis H. Cavanaugh

Equivalents at a Crossroad
by Clark Sullivan

Halperin Named New FDLI President
by Stephanie L. Scott

New Markets, New Demands: Biotechnology and the Fundamental Shift in Market Segmentation
by Juliet A. Zavon

FDCA Preemption of Common—Law Tort Claims Reinvigorated by the Supreme Court
by James M. Beck

FDA's Crackdown on Cholesterol Structure/Functional Claims: A Portent of Policies to Come?
by Jeffrey N. Wasserstein

New HHS Privacy Rule Will Have Sweeping Impact on the Pharmaceutical Industry
by John T. Bentivoglio and Benjamin S. Martin

Pharmacogenomics: The Uncertain Path to Decoding the Regulatory Genome
by James N. Czaban

Making History
A Modern Vaccine Miracle: John Robbins and the Hib Vaccine
by Suzanne White Junod

Enforcement Corner
Enforcement Focus on Reimbursement for Prescription Drugs
by Steven M. Kowal

Global Corner
Registration of Generic Drugs in the European Union: Challenge and Opportunity
by Sophie G. Anderson

Associates' Corner
An Armed Truce: Drug Master Files in Supply Agreements
by Amy Fortenberry